Analytical Data
-
Gene name
C22orf28
- Application
-
Alternative Names
RTCB; tRNA-Splicing Ligase RtcB Homolog
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y3I0
-
Expression Region
Met1~Gly505
-
Molecular Weight
59kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C22orf28, also known as "Chromosome 22 open reading frame 28," is a gene of emerging interest in the field of molecular biology and genetics due to its potential implications in human health and disease. Found on chromosome 22, C22orf28 encodes a protein whose exact biological functions remain largely unexplored, making it a subject of significant research attention. Recent studies have suggested that this protein may be involved in critical cellular processes, including cell proliferation, apoptosis, and DNA repair, indicating its potential role in cancer biology and other disorders. Moreover, variations in the C22orf28 gene have been associated with certain genetic conditions, prompting investigations into its involvement in various diseases. The expression and functional characterization of recombinant C22orf28 protein are essential steps for elucidating its role in physiological and pathological contexts. By producing and studying this protein in vitro, researchers aim to uncover its biochemical properties, interaction partners, and potential pathways in which it may be involved. Understanding the molecular mechanisms linked to C22orf28 could contribute to the development of therapeutic strategies and enhance our comprehension of its contribution to human health. As studies progress, the exploration of C22orf28's role in cell signaling and its potential as a biomarker or therapeutic target holds promise for future breakthroughs in medical research.
